1
|
Galasso C, Ruocco N, Mutalipassi M, Barra L, Costa V, Giommi C, Dinoi A, Genovese M, Pica D, Romano C, Greco S, Pennesi C. Marine polysaccharides, proteins, lipids, and silica for drug delivery systems: A review. Int J Biol Macromol 2023; 253:127145. [PMID: 37778590 DOI: 10.1016/j.ijbiomac.2023.127145] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Revised: 09/27/2023] [Accepted: 09/28/2023] [Indexed: 10/03/2023]
Abstract
Marine environments represent an incredible source of biopolymers with potential biomedical applications. Recently, drug delivery studies have received great attention for the increasing need to improve site specificity, therapeutic value, and bioavailability, reducing off-target effects. Marine polymers, such as alginate, carrageenan, collagen, chitosan, and silica, have reported unique biochemical features, allowing an efficient binding with drugs, and a controlled release to the target tissue, also obtainable through "green processes". In the present review, we i) analysed the last ten years of scientific peer-reviewed literature; ii) divided the articles based on the achieved experimental phases, tagged as chemistry, drug release, and drug delivery, and iii) compared the best performances among marine polymers extracted from micro- and macro-organisms. Many reviews describe drug carriers from marine organisms, focusing on a single biopolymer or a chemical class. Our study is a groundbreaking literature collection, representing the first thorough investigation of all marine biopolymers described. Most articles report experimental results on the chemical characterisation of marine biopolymers and their in vitro behaviour as drug carriers, although development processes and commercial applications are still in the early stages. Hence, the next efforts should be focused on the sustainable production of marine polymers and final product development.
Collapse
Affiliation(s)
- Christian Galasso
- Department of Ecosustainable Marine Biotechnology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy.
| | - Nadia Ruocco
- Department of Ecosustainable Marine Biotechnology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy.
| | - Mirko Mutalipassi
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy; NBFC, National Biodiversity Future Center, Piazza Marina 61, 90133 Palermo, Italy
| | - Lucia Barra
- Department of Ecosustainable Marine Biotechnology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Valentina Costa
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Chiara Giommi
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Alessia Dinoi
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Martina Genovese
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Daniela Pica
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Chiara Romano
- University of Gastronomic Sciences, Piazza Vittorio Emanuele II, 9, 12042 Pollenzo, Bra CN, Italy
| | - Silvestro Greco
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy
| | - Chiara Pennesi
- Department of Integrative Marine Ecology, Stazione Zoologica Anton Dohrn, Calabria Marine Centre, C.da Torre Spaccata, Amendolara, Italy.
| |
Collapse
|
2
|
Kadota K, Mikami T, Kohata A, Morimoto J, Sando S, Aikawa K, Okazoe T. Synthesis of Short Peptides with Perfluoroalkyl Side Chains and Evaluation of Their Cellular Uptake Efficiency. Chembiochem 2023; 24:e202300374. [PMID: 37430341 DOI: 10.1002/cbic.202300374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Revised: 07/07/2023] [Accepted: 07/10/2023] [Indexed: 07/12/2023]
Abstract
With an increasing demand for macromolecular biotherapeutics, the issue of their poor cell-penetrating abilities requires viable and relevant solutions. Herein, we report tripeptides bearing an amino acid with a perfluoroalkyl (RF ) group adjacent to the α-carbon. RF -containing tripeptides were synthesized and evaluated for their ability to transport a conjugated hydrophilic dye (Alexa Fluor 647) into the cells. RF -containing tripeptides with the fluorophore showed high cellular uptake efficiency and none of them were cytotoxic. Interestingly, we demonstrated that the absolute configuration of perfluoroalkylated amino acids (RF -AAs) affects not only nanoparticle formation but also the cell permeability of the tripeptides. These novel RF -containing tripeptides are potentially useful as short and noncationic cell-penetrating peptides (CPPs).
Collapse
Affiliation(s)
- Koji Kadota
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032, Japan
| | - Toshiki Mikami
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032, Japan
| | - Ai Kohata
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032, Japan
| | - Jumpei Morimoto
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan
| | - Shinsuke Sando
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan
- Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan
| | - Kohsuke Aikawa
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032, Japan
| | - Takashi Okazoe
- Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo, 113-0032, Japan
- Yokohama Technical Center, AGC Inc., 1-1 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan
| |
Collapse
|
3
|
Rudakovskaya PG, Barmin RA, Kuzmin PS, Fedotkina EP, Sencha AN, Gorin DA. Microbubbles Stabilized by Protein Shell: From Pioneering Ultrasound Contrast Agents to Advanced Theranostic Systems. Pharmaceutics 2022; 14:1236. [PMID: 35745808 PMCID: PMC9227336 DOI: 10.3390/pharmaceutics14061236] [Citation(s) in RCA: 16] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2022] [Revised: 05/07/2022] [Accepted: 05/13/2022] [Indexed: 12/16/2022] Open
Abstract
Ultrasound is a widely-used imaging modality in clinics as a low-cost, non-invasive, non-radiative procedure allowing therapists faster decision-making. Microbubbles have been used as ultrasound contrast agents for decades, while recent attention has been attracted to consider them as stimuli-responsive drug delivery systems. Pioneering microbubbles were Albunex with a protein shell composed of human serum albumin, which entered clinical practice in 1993. However, current research expanded the set of proteins for a microbubble shell beyond albumin and applications of protein microbubbles beyond ultrasound imaging. Hence, this review summarizes all-known protein microbubbles over decades with a critical evaluation of formulations and applications to optimize the safety (low toxicity and high biocompatibility) as well as imaging efficiency. We provide a comprehensive overview of (1) proteins involved in microbubble formulation, (2) peculiarities of preparation of protein stabilized microbubbles with consideration of large-scale production, (3) key chemical factors of stabilization and functionalization of protein-shelled microbubbles, and (4) biomedical applications beyond ultrasound imaging (multimodal imaging, drug/gene delivery with attention to anticancer treatment, antibacterial activity, biosensing). Presented critical evaluation of the current state-of-the-art for protein microbubbles should focus the field on relevant strategies in microbubble formulation and application for short-term clinical translation. Thus, a protein bubble-based platform is very perspective for theranostic application in clinics.
Collapse
Affiliation(s)
- Polina G. Rudakovskaya
- Center for Photonic Science and Engineering, Skolkovo Institute of Science and Technology, Nobel Str. 3, 121205 Moscow, Russia;
| | - Roman A. Barmin
- Center for Photonic Science and Engineering, Skolkovo Institute of Science and Technology, Nobel Str. 3, 121205 Moscow, Russia;
| | - Pavel S. Kuzmin
- Institute of Materials for Modern Energy and Nanotechnology, Dmitry Mendeleev University of Chemical Technology of Russia, Miusskaya Sq. 9, 125047 Moscow, Russia;
| | - Elena P. Fedotkina
- Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of the Russian Federation, Akademika Oparina Str. 4, 117198 Moscow, Russia; (E.P.F.); (A.N.S.)
| | - Alexander N. Sencha
- Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Healthcare of the Russian Federation, Akademika Oparina Str. 4, 117198 Moscow, Russia; (E.P.F.); (A.N.S.)
| | - Dmitry A. Gorin
- Center for Photonic Science and Engineering, Skolkovo Institute of Science and Technology, Nobel Str. 3, 121205 Moscow, Russia;
| |
Collapse
|
4
|
Uddin S, Islam MR, Md Moshikur R, Wakabayashi R, Kamiya N, Moniruzzaman M, Goto M. Transdermal Delivery of Antigenic Protein Using Ionic Liquid-Based Nanocarriers for Tumor Immunotherapy. ACS APPLIED BIO MATERIALS 2022; 5:2586-2597. [PMID: 35472266 DOI: 10.1021/acsabm.2c00061] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Transdermal drug delivery systems (TDDSs) may be useful for preventing various diseases including cancer. However, the stratum corneum (SC) inhibits the permeation of foreign particles into the skin. To obtain an effective TDDS, we developed a protein-containing nanocarrier (PCNC) comprising an antigenic protein (ovalbumin/OVA) stabilized by a combination of surfactants, i.e., a lipid-based surface-active ionic liquid and Tween-80. The PCNC was lyophilized to remove water and cyclohexane and then dispersed in isopropyl myristate. It is biocompatible both in vitro and in vivo, and is suitable for use in a therapeutic TDDS. The skin permeability of the PCNC was significantly (p < 0.0001) enhanced, and the transdermal distribution and transdermal flux of the OVA delivery system were 25 and 28 times greater, respectively, than those of its aqueous formulation. The PCNC disrupted the order of lipid orientation in the skin's SC and increased intercellular protein delivery. It demonstrated effective antitumor activity, drastically (p < 0.001) suppressed tumor growth, increased mouse survival rates, and significantly (p < 0.001) stimulated the OVA-specific tumor immune response. The PCNC also increased the number of cytotoxic T cells expressing CD8 antibodies on their surfaces (CD8 + T-cells) in the tumor microenvironment. These findings suggest that PCNCs may be promising biocompatible carriers for transdermal antigenic protein delivery in tumor immunotherapy.
Collapse
Affiliation(s)
- Shihab Uddin
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
| | - Md Rafiqul Islam
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.,Department of Applied Chemistry and Chemical Engineering, Noakhali Science and Technology University, Noakhali 3814, Bangladesh
| | - Rahman Md Moshikur
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
| | - Rie Wakabayashi
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.,Advanced Transdermal Drug Delivery System Centre, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
| | - Noriho Kamiya
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.,Advanced Transdermal Drug Delivery System Centre, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.,Division of Biotechnology, Centre for Future Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
| | - Muhammad Moniruzzaman
- Department of Chemical Engineering, Universiti Teknologi PETRONAS, 32610 Seri Iskandar, Perak, Malaysia
| | - Masahiro Goto
- Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.,Advanced Transdermal Drug Delivery System Centre, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan.,Division of Biotechnology, Centre for Future Chemistry, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan
| |
Collapse
|
5
|
Theodoroula NF, Karavasili C, Vlasiou MC, Primikyri A, Nicolaou C, Chatzikonstantinou AV, Chatzitaki AT, Petrou C, Bouropoulos N, Zacharis CK, Galatou E, Sarigiannis Y, Fatouros DG, Vizirianakis IS. NGIWY-Amide: A Bioinspired Ultrashort Self-Assembled Peptide Gelator for Local Drug Delivery Applications. Pharmaceutics 2022; 14:133. [PMID: 35057029 PMCID: PMC8778326 DOI: 10.3390/pharmaceutics14010133] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Revised: 12/30/2021] [Accepted: 12/31/2021] [Indexed: 01/14/2023] Open
Abstract
Fibrillar structures derived from plant or animal origin have long been a source of inspiration for the design of new biomaterials. The Asn-Gly-Ile-Trp-Tyr-NH2 (NGIWY-amide) pentapeptide, isolated from the sea cucumber Apostichopus japonicus, which spontaneously self-assembles in water to form hydrogel, pertains to this category. In this study, we evaluated this ultra-short cosmetic bioinspired peptide as vector for local drug delivery applications. Combining nuclear magnetic resonance, circular dichroism, infrared spectroscopy, X-ray diffraction, and rheological studies, the synthesized pentapeptide formed a stiff hydrogel with a high β-sheet content. Molecular dynamic simulations aligned well with scanning electron and atomic-force microscopy studies, revealing a highly filamentous structure with the fibers adopting a helical-twisted morphology. Model dye localization within the supramolecular hydrogel provided insights on the preferential distribution of hydrophobic and hydrophilic compounds in the hydrogel network. That was further depicted in the diffusion kinetics of drugs differing in their aqueous solubility and molecular weight, namely, doxorubicin hydrochloride, curcumin, and octreotide acetate, highlighting its versatility as a delivery vector of both hydrophobic and hydrophilic compounds of different molecular weight. Along with the observed cytocompatibility of the hydrogel, the NGIWY-amide pentapeptide may offer new approaches for cell growth, drug delivery, and 3D bioprinting tissue-engineering applications.
Collapse
Affiliation(s)
- Nikoleta F. Theodoroula
- Department of Molecular Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece;
| | - Christina Karavasili
- Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.K.); (A.-T.C.); (D.G.F.)
| | - Manos C. Vlasiou
- Department of Life & Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; (M.C.V.); (C.N.); (C.P.); (E.G.)
| | | | - Christia Nicolaou
- Department of Life & Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; (M.C.V.); (C.N.); (C.P.); (E.G.)
| | - Alexandra V. Chatzikonstantinou
- Biotechnology Laboratory, Department of Biological Applications and Technologies, University of Ioannina, 45110 Ioannina, Greece;
| | - Aikaterini-Theodora Chatzitaki
- Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.K.); (A.-T.C.); (D.G.F.)
| | - Christos Petrou
- Department of Life & Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; (M.C.V.); (C.N.); (C.P.); (E.G.)
| | - Nikolaos Bouropoulos
- Department of Materials Science, University of Patras, 26504 Patras, Greece;
- Foundation for Research and Technology Hellas, Institute of Chemical Engineering and High Temperature Chemical Processes, 26504 Patras, Greece
| | - Constantinos K. Zacharis
- Laboratory of Pharmaceutical Analysis, Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece;
| | - Eleftheria Galatou
- Department of Life & Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; (M.C.V.); (C.N.); (C.P.); (E.G.)
| | - Yiannis Sarigiannis
- Department of Life & Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; (M.C.V.); (C.N.); (C.P.); (E.G.)
| | - Dimitrios G. Fatouros
- Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece; (C.K.); (A.-T.C.); (D.G.F.)
| | - Ioannis S. Vizirianakis
- Department of Molecular Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece;
- Department of Life & Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; (M.C.V.); (C.N.); (C.P.); (E.G.)
| |
Collapse
|